An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · cited 1×
“Angiotensin receptor antagonists and inhibitors of angiotensin-converting enzyme (ACE) reduce cardiac hypertrophy, reverse cardiac remodeling, and delay the progression of heart failure in myocardial infarction (Cohn et al., 2001; Pfeffer et al., 1992; Pitt et al., 2000).”
BackgroundSakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · cited 1×
“Studies in both human and animal models demonstrated that ghrelin secretion levels are increased by chronic food deprivation and fasting, whereas food intake reduces circulating levels of ghrelin (Cummings et al., 2001; Drazen et al., 2006).”
BackgroundThe structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534 · cited 1×
“As the most prolific superfamily of cell-membrane proteins, with approximately 800 members, GPCRs modulate diverse cellular responses to themajority of neurotransmitters and hormones within the human body (Rosenbaum et al., 2009).”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · cited 3×
“This increases heat production and energy expenditure through increased mitochondrial activity (Watanabe et al., 2006).”
BackgroundInfluentialEpidemiology of Diabetes and Diabetes-Related Complications
Deshpande, A. D., Harris-Hayes, M., & Schootman, M. (2008) · Physical Therapy · doi:10.2522/ptj.20080020 · Cited by 1,773 · cited 1×
“The onset of this disease leads to other secondary complications, such as kidney failure, retinopathy and cardiovascular diseases (Deshpande et al., 2008).”
BackgroundBody Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481 · cited 1×
“older populations in developed countries (Després, 2012).”
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847 · cited 2×
“catenin signaling, as seen by overexpression of both Wnt receptors and ligands in cancerous tissues (Park et al., 2009; Polakis, 2012).”
BackgroundThe secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
G protein-coupled receptors: novel targets for drug discovery in cancer
Lappano, R., & Maggiolini, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3320 · Cited by 717
The alliance of sphingosine-1-phosphate and its receptors in immunity
Rivera, J., Proia, R. L., & Olivera, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2400 · Cited by 616 · cited 2×
“…widely expressed on most immune cells (unlike the other four S1PR receptor subtypes with a more restricted distribution), the release of sphingosine-1-phosphate by mast cells also stimulates the chemotactic migration of other immune cells involved in the inflammatory process (Rivera et al., 2008).”
BackgroundHuang, S., Apasov, S., Koshiba, M., & Sitkovsky, M. (1997) · Blood · doi:10.1182/blood.v90.4.1600 · Cited by 531 · cited 1×
“In contrast, A2A receptor signaling exerts anti-inflammatory effects, such as inhibition of T-cell activation (Huang et al., 1997) and downregulating expression of pro-inflammatory cytokines (Haskó et al., 2000).”
BackgroundThe basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359 · cited 2×
“These cause major physical disruption to the basal ganglia-thalamocortical motor circuit that play a key role in controlling motor activity (Obeso et al., 2008).”
BackgroundDrazen, D. L., Vahl, T. P., D’Alessio, D. A., Seeley, R. J., & Woods, S. C. (2006) · Endocrinology · doi:10.1210/en.2005-0973 · Cited by 334
Regulation of the immune response and inflammation by histamine and histamine receptors
O’Mahony, L., Akdis, M., & Akdis, C. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.051 · Cited by 313
Moens, K., Heimberg, H., Flamez, D., Huypens, P., Quartier, E., Ling, Z., Pipeleers, D., Gremlich, S., Thorens, B., & Schuit, F. (1996) · Diabetes · doi:10.2337/diab.45.2.257 · Cited by 250 · cited 1×
“However, its expression by pancreatic α and δ cells is controversial, due to conflicting data (Heller et al., 1997; Moens et al., 1996; Tornehave et al., 2008).”
BackgroundRozengurt, E., Sinnett-Smith, J., & Kisfalvi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2229 · Cited by 247 · cited 2×
“Activating InsR/IGF1R signaling potentiates Ca2+ signaling and phosphotidylinositol 4,5-biphosphate hydrolysis induced by various Gq-protein coupled receptor agonists (Rozengurt et al., 2010).”
BackgroundHay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · cited 4×
“…therapeutic effect on Alzheimer's disease (Cochet et al., 2013; Geldenhuys and Van der Schyf, 2009; Kim et al., 2010; Lezoualc'h, 2007; Movsesyan et al., 2004; Nitsch et al., 1996; Pedersen et al., 2001; Rat et al., 2011; Rossner et al., 1998; Russo et al., 2009; Spampinato et al., 2012).”
BackgroundInfluentialThe serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Heller, R. S., Kieffer, T. J., & Habener, J. F. (1997) · Diabetes · doi:10.2337/diab.46.5.785 · Cited by 179
Taborsky, G. J., & Mundinger, T. O. (2012) · Endocrinology · doi:10.1210/en.2011-2040 · Cited by 140
Oshikawa, S., Tanoue, A., Koshimizu, T.-A., Kitagawa, Y., & Tsujimoto, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.623 · Cited by 105 · cited 1×
“There are three subtypes of vasopressin receptor (V1A, V1B and V2), but only the V1B subtype stimulates secretion of insulin and glucagon when activated by vasopressin (Oshikawa et al., 2004).”
BackgroundNeurokinin mediation of edema and inflammation
Campos, M. M., & Calixto, J. B. (2000) · Neuropeptides · doi:10.1054/npep.2000.0823 · Cited by 102 · cited 1×
“The various pro-inflammatory effects mediated by neurokinin receptor signaling include stimulating the release of histamine, nitric oxide and kinins, promoting vasodilatation, protein plasma extravasation, edema formation, and leucocyte migration (Bost, 2004; Campos and Calixto, 2000).”
BackgroundCardiac and neuroprotection regulated by α1-adrenergic receptor subtypes
Perez, D. M., & Doze, V. A. (2011) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.550008 · Cited by 59
Cited by
The Gut Microbiome and the Brain
Galland, L. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.7000 · Cited by 648
“96 SCFAs activate two specific GPCRs (GPR41 and GPR43) that have no other known ligands.”
GPR75: an exciting new target in metabolic syndrome and related disorders
Murtaza, B., Asghar, F., & Patoli, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.005 · Cited by 18
Mechanism of Tethered Agonist Binding to an Adhesion G-Protein-Coupled Receptor
(2025) · doi:10.1021/acs.jpcb.5c05305 · Cited by 4
Metadata
- Authors
- Heng, B. C., Aubel, D., & Fussenegger, M.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 31
- Issue
- 8
- Pages
- 1676-1694
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2044618021
- Cited by
- 204
- References
- 28
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.